Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-03-05

AUTHORS

Giovanni Ferrara, Lisen Arnheim-Dahlström, Karen Bartley, Christer Janson, Klaus-Uwe Kirchgässler, Aaron Levine, C. Magnus Sköld

ABSTRACT

INTRODUCTION: Data on the epidemiology of idiopathic pulmonary fibrosis (IPF) in Sweden are lacking. This study estimates the incidence and prevalence of IPF in Sweden, and describes the demographic and clinical characteristics and the overall survival of patients with IPF. METHODS: Two cohorts were studied: a national cohort of 17,247 patients with pulmonary fibrosis (ICD-10 code J84.1 with no competing diagnosis) from the Swedish National Patient Register (cohort 1 [C1]); and an electronic medical record-based regional subset of C1 comprising 1755 patients having pulmonary fibrosis and a radiology procedure (C2). RESULTS: The incidence of pulmonary fibrosis in C1 ranged from 10.4 to 15.4 cases per 100,000 population per year between 2001 and 2015. The prevalence increased from 15.4 to 68.0 cases per 100,000 population per year. Patients ≥ 70 years and men had a higher incidence and prevalence of pulmonary fibrosis. Common comorbidities included respiratory infections and cardiovascular disorders. Approximately one-third of patients in each cohort were hospitalised with pulmonary fibrosis within a year of diagnosis. The median survival time from disease diagnosis was 2.6 years in C1 and 5.2 years in C2. Older patients had a higher risk of hospitalisation and mortality. Women had a better prognosis than men. CONCLUSION: This study underscores the importance of pulmonary fibrosis as a cause of respiratory-related morbidity and mortality in Sweden. The stable incidence and increasing prevalence over time suggests longer survival. The higher morbidity and mortality in older patients highlights the importance of early case detection, diagnosis and management for better prognosis. FUNDING: F. Hoffmann-La Roche, Ltd./Genentech, Inc. More... »

PAGES

55-68

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s41030-019-0087-9

DOI

http://dx.doi.org/10.1007/s41030-019-0087-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112541270

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/32026424


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden", 
            "Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferrara", 
        "givenName": "Giovanni", 
        "id": "sg:person.01233251104.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233251104.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "IQVIA, Solna, Sweden", 
            "Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arnheim-Dahlstr\u00f6m", 
        "givenName": "Lisen", 
        "id": "sg:person.01175417457.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175417457.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Genentech, Inc., South San Francisco, CA USA", 
          "id": "http://www.grid.ac/institutes/grid.418158.1", 
          "name": [
            "Genentech, Inc., South San Francisco, CA USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bartley", 
        "givenName": "Karen", 
        "id": "sg:person.011137006010.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011137006010.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Janson", 
        "givenName": "Christer", 
        "id": "sg:person.01107225232.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107225232.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "F. Hoffmann-La Roche, Ltd., Basel, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.417570.0", 
          "name": [
            "F. Hoffmann-La Roche, Ltd., Basel, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kirchg\u00e4ssler", 
        "givenName": "Klaus-Uwe", 
        "id": "sg:person.015451312474.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015451312474.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "IQVIA, Solna, Sweden", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "IQVIA, Solna, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Levine", 
        "givenName": "Aaron", 
        "id": "sg:person.015113461475.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015113461475.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden", 
            "Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sk\u00f6ld", 
        "givenName": "C. Magnus", 
        "id": "sg:person.01245151223.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245151223.63"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s12931-016-0461-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003754552", 
          "https://doi.org/10.1186/s12931-016-0461-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10654-017-0316-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092101190", 
          "https://doi.org/10.1007/s10654-017-0316-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/jhh.2009.77", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014438714", 
          "https://doi.org/10.1038/jhh.2009.77"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-03-05", 
    "datePublishedReg": "2019-03-05", 
    "description": "INTRODUCTION: Data on the epidemiology of idiopathic pulmonary fibrosis (IPF) in Sweden are lacking. This study estimates the incidence and prevalence of IPF in Sweden, and describes the demographic and clinical characteristics and the overall survival of patients with IPF.\nMETHODS: Two cohorts were studied: a national cohort of 17,247 patients with pulmonary fibrosis (ICD-10 code J84.1 with no competing diagnosis) from the Swedish National Patient Register (cohort 1 [C1]); and an electronic medical record-based regional subset of C1 comprising 1755 patients having pulmonary fibrosis and a radiology procedure (C2).\nRESULTS: The incidence of pulmonary fibrosis in C1 ranged from 10.4 to 15.4 cases per 100,000 population per year between 2001 and 2015. The prevalence increased from 15.4 to 68.0 cases per 100,000 population per year. Patients\u2009\u2265\u200970\u00a0years and men had a higher incidence and prevalence of pulmonary fibrosis. Common comorbidities included respiratory infections and cardiovascular disorders. Approximately one-third of patients in each cohort were hospitalised with pulmonary fibrosis within a year of diagnosis. The median survival time from disease diagnosis was 2.6\u00a0years in C1 and 5.2\u00a0years in C2. Older patients had a higher risk of hospitalisation and mortality. Women had a better prognosis than men.\nCONCLUSION: This study underscores the importance of pulmonary fibrosis as a cause of respiratory-related morbidity and mortality in Sweden. The stable incidence and increasing prevalence over time suggests longer survival. The higher morbidity and mortality in older patients highlights the importance of early case detection, diagnosis and management for better prognosis.\nFUNDING: F. Hoffmann-La Roche, Ltd./Genentech, Inc.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s41030-019-0087-9", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1136859", 
        "issn": [
          "2364-1754", 
          "2364-1746"
        ], 
        "name": "Pulmonary Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "idiopathic pulmonary fibrosis", 
      "pulmonary fibrosis", 
      "older patients", 
      "better prognosis", 
      "prevalence of IPF", 
      "Swedish National Patient Register", 
      "respiratory-related morbidity", 
      "National Patient Register", 
      "year of diagnosis", 
      "early case detection", 
      "median survival time", 
      "clinical characteristics", 
      "Patient Register", 
      "overall survival", 
      "common comorbidities", 
      "respiratory infections", 
      "stable incidence", 
      "high morbidity", 
      "national cohort", 
      "longer survival", 
      "case detection", 
      "high risk", 
      "cardiovascular disorders", 
      "survival time", 
      "high incidence", 
      "patients", 
      "fibrosis", 
      "prevalence", 
      "incidence", 
      "radiology procedures", 
      "Hoffmann-La Roche", 
      "cohort", 
      "mortality", 
      "diagnosis", 
      "morbidity", 
      "prognosis", 
      "one-third", 
      "epidemiology", 
      "survival", 
      "men", 
      "years", 
      "disease diagnosis", 
      "hospitalisation", 
      "comorbidities", 
      "population", 
      "infection", 
      "women", 
      "disorders", 
      "healthcare data", 
      "risk", 
      "study", 
      "cases", 
      "Sweden", 
      "cause", 
      "Register", 
      "Roche", 
      "C1", 
      "subset", 
      "management", 
      "data", 
      "time", 
      "procedure", 
      "importance", 
      "regional subsets", 
      "detection", 
      "characteristics", 
      "C2", 
      "electronic medical record-based regional subset", 
      "medical record-based regional subset", 
      "record-based regional subset", 
      "Ltd./Genentech", 
      "Inc. Epidemiology", 
      "Cohort Study Using Healthcare Data", 
      "Study Using Healthcare Data", 
      "Using Healthcare Data"
    ], 
    "name": "Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden", 
    "pagination": "55-68", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112541270"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s41030-019-0087-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "32026424"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s41030-019-0087-9", 
      "https://app.dimensions.ai/details/publication/pub.1112541270"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:46", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_822.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s41030-019-0087-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s41030-019-0087-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s41030-019-0087-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s41030-019-0087-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s41030-019-0087-9'


 

This table displays all metadata directly associated to this object as RDF triples.

215 TRIPLES      22 PREDICATES      106 URIs      93 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s41030-019-0087-9 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 anzsrc-for:1103
4 anzsrc-for:1117
5 schema:author N1247b4e030e448b3b6ce150abf8a5880
6 schema:citation sg:pub.10.1007/s10654-017-0316-1
7 sg:pub.10.1038/jhh.2009.77
8 sg:pub.10.1186/s12931-016-0461-1
9 schema:datePublished 2019-03-05
10 schema:datePublishedReg 2019-03-05
11 schema:description INTRODUCTION: Data on the epidemiology of idiopathic pulmonary fibrosis (IPF) in Sweden are lacking. This study estimates the incidence and prevalence of IPF in Sweden, and describes the demographic and clinical characteristics and the overall survival of patients with IPF. METHODS: Two cohorts were studied: a national cohort of 17,247 patients with pulmonary fibrosis (ICD-10 code J84.1 with no competing diagnosis) from the Swedish National Patient Register (cohort 1 [C1]); and an electronic medical record-based regional subset of C1 comprising 1755 patients having pulmonary fibrosis and a radiology procedure (C2). RESULTS: The incidence of pulmonary fibrosis in C1 ranged from 10.4 to 15.4 cases per 100,000 population per year between 2001 and 2015. The prevalence increased from 15.4 to 68.0 cases per 100,000 population per year. Patients ≥ 70 years and men had a higher incidence and prevalence of pulmonary fibrosis. Common comorbidities included respiratory infections and cardiovascular disorders. Approximately one-third of patients in each cohort were hospitalised with pulmonary fibrosis within a year of diagnosis. The median survival time from disease diagnosis was 2.6 years in C1 and 5.2 years in C2. Older patients had a higher risk of hospitalisation and mortality. Women had a better prognosis than men. CONCLUSION: This study underscores the importance of pulmonary fibrosis as a cause of respiratory-related morbidity and mortality in Sweden. The stable incidence and increasing prevalence over time suggests longer survival. The higher morbidity and mortality in older patients highlights the importance of early case detection, diagnosis and management for better prognosis. FUNDING: F. Hoffmann-La Roche, Ltd./Genentech, Inc.
12 schema:genre article
13 schema:inLanguage en
14 schema:isAccessibleForFree true
15 schema:isPartOf Nc6cdfb0d56a3460987c6bdd10d91ab3e
16 Nca1f8f8e7ec74378a3470e421250f85d
17 sg:journal.1136859
18 schema:keywords C1
19 C2
20 Cohort Study Using Healthcare Data
21 Hoffmann-La Roche
22 Inc. Epidemiology
23 Ltd./Genentech
24 National Patient Register
25 Patient Register
26 Register
27 Roche
28 Study Using Healthcare Data
29 Sweden
30 Swedish National Patient Register
31 Using Healthcare Data
32 better prognosis
33 cardiovascular disorders
34 case detection
35 cases
36 cause
37 characteristics
38 clinical characteristics
39 cohort
40 common comorbidities
41 comorbidities
42 data
43 detection
44 diagnosis
45 disease diagnosis
46 disorders
47 early case detection
48 electronic medical record-based regional subset
49 epidemiology
50 fibrosis
51 healthcare data
52 high incidence
53 high morbidity
54 high risk
55 hospitalisation
56 idiopathic pulmonary fibrosis
57 importance
58 incidence
59 infection
60 longer survival
61 management
62 median survival time
63 medical record-based regional subset
64 men
65 morbidity
66 mortality
67 national cohort
68 older patients
69 one-third
70 overall survival
71 patients
72 population
73 prevalence
74 prevalence of IPF
75 procedure
76 prognosis
77 pulmonary fibrosis
78 radiology procedures
79 record-based regional subset
80 regional subsets
81 respiratory infections
82 respiratory-related morbidity
83 risk
84 stable incidence
85 study
86 subset
87 survival
88 survival time
89 time
90 women
91 year of diagnosis
92 years
93 schema:name Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden
94 schema:pagination 55-68
95 schema:productId N1f85def902a344a9a405011ddafef261
96 N4b63c7f8d1064b68954bf10f0a2cc5b2
97 N87a9b179cf5942b99f26ff43b6704d78
98 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112541270
99 https://doi.org/10.1007/s41030-019-0087-9
100 schema:sdDatePublished 2021-12-01T19:46
101 schema:sdLicense https://scigraph.springernature.com/explorer/license/
102 schema:sdPublisher N4ec382889b1045ebb529191f6e672f76
103 schema:url https://doi.org/10.1007/s41030-019-0087-9
104 sgo:license sg:explorer/license/
105 sgo:sdDataset articles
106 rdf:type schema:ScholarlyArticle
107 N1247b4e030e448b3b6ce150abf8a5880 rdf:first sg:person.01233251104.39
108 rdf:rest Ne149a837327741c28f0cda5b08d83dfc
109 N1f85def902a344a9a405011ddafef261 schema:name dimensions_id
110 schema:value pub.1112541270
111 rdf:type schema:PropertyValue
112 N2aa2e6c0b5364273906cd3c30411aea4 rdf:first sg:person.015113461475.27
113 rdf:rest N7e6150965aa144ea8b94b0422d6fbd1d
114 N36ce8a3677384bd0bc8e8c36298c6a82 rdf:first sg:person.011137006010.21
115 rdf:rest Nac8a06bc0bc246e690232c17e5c2f188
116 N4b63c7f8d1064b68954bf10f0a2cc5b2 schema:name pubmed_id
117 schema:value 32026424
118 rdf:type schema:PropertyValue
119 N4ec382889b1045ebb529191f6e672f76 schema:name Springer Nature - SN SciGraph project
120 rdf:type schema:Organization
121 N7e6150965aa144ea8b94b0422d6fbd1d rdf:first sg:person.01245151223.63
122 rdf:rest rdf:nil
123 N87a9b179cf5942b99f26ff43b6704d78 schema:name doi
124 schema:value 10.1007/s41030-019-0087-9
125 rdf:type schema:PropertyValue
126 Nac8a06bc0bc246e690232c17e5c2f188 rdf:first sg:person.01107225232.22
127 rdf:rest Ndcebfd3868a148e7acaa775f07e1543c
128 Nc6cdfb0d56a3460987c6bdd10d91ab3e schema:volumeNumber 5
129 rdf:type schema:PublicationVolume
130 Nca1f8f8e7ec74378a3470e421250f85d schema:issueNumber 1
131 rdf:type schema:PublicationIssue
132 Ndcebfd3868a148e7acaa775f07e1543c rdf:first sg:person.015451312474.44
133 rdf:rest N2aa2e6c0b5364273906cd3c30411aea4
134 Ne149a837327741c28f0cda5b08d83dfc rdf:first sg:person.01175417457.59
135 rdf:rest N36ce8a3677384bd0bc8e8c36298c6a82
136 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
137 schema:name Medical and Health Sciences
138 rdf:type schema:DefinedTerm
139 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
140 schema:name Cardiorespiratory Medicine and Haematology
141 rdf:type schema:DefinedTerm
142 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
143 schema:name Clinical Sciences
144 rdf:type schema:DefinedTerm
145 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
146 schema:name Public Health and Health Services
147 rdf:type schema:DefinedTerm
148 sg:journal.1136859 schema:issn 2364-1746
149 2364-1754
150 schema:name Pulmonary Therapy
151 schema:publisher Springer Nature
152 rdf:type schema:Periodical
153 sg:person.01107225232.22 schema:affiliation grid-institutes:grid.8993.b
154 schema:familyName Janson
155 schema:givenName Christer
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107225232.22
157 rdf:type schema:Person
158 sg:person.011137006010.21 schema:affiliation grid-institutes:grid.418158.1
159 schema:familyName Bartley
160 schema:givenName Karen
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011137006010.21
162 rdf:type schema:Person
163 sg:person.01175417457.59 schema:affiliation grid-institutes:grid.4714.6
164 schema:familyName Arnheim-Dahlström
165 schema:givenName Lisen
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175417457.59
167 rdf:type schema:Person
168 sg:person.01233251104.39 schema:affiliation grid-institutes:grid.4714.6
169 schema:familyName Ferrara
170 schema:givenName Giovanni
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233251104.39
172 rdf:type schema:Person
173 sg:person.01245151223.63 schema:affiliation grid-institutes:grid.4714.6
174 schema:familyName Sköld
175 schema:givenName C. Magnus
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245151223.63
177 rdf:type schema:Person
178 sg:person.015113461475.27 schema:affiliation grid-institutes:None
179 schema:familyName Levine
180 schema:givenName Aaron
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015113461475.27
182 rdf:type schema:Person
183 sg:person.015451312474.44 schema:affiliation grid-institutes:grid.417570.0
184 schema:familyName Kirchgässler
185 schema:givenName Klaus-Uwe
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015451312474.44
187 rdf:type schema:Person
188 sg:pub.10.1007/s10654-017-0316-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092101190
189 https://doi.org/10.1007/s10654-017-0316-1
190 rdf:type schema:CreativeWork
191 sg:pub.10.1038/jhh.2009.77 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014438714
192 https://doi.org/10.1038/jhh.2009.77
193 rdf:type schema:CreativeWork
194 sg:pub.10.1186/s12931-016-0461-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003754552
195 https://doi.org/10.1186/s12931-016-0461-1
196 rdf:type schema:CreativeWork
197 grid-institutes:None schema:alternateName IQVIA, Solna, Sweden
198 schema:name IQVIA, Solna, Sweden
199 rdf:type schema:Organization
200 grid-institutes:grid.417570.0 schema:alternateName F. Hoffmann-La Roche, Ltd., Basel, Switzerland
201 schema:name F. Hoffmann-La Roche, Ltd., Basel, Switzerland
202 rdf:type schema:Organization
203 grid-institutes:grid.418158.1 schema:alternateName Genentech, Inc., South San Francisco, CA USA
204 schema:name Genentech, Inc., South San Francisco, CA USA
205 rdf:type schema:Organization
206 grid-institutes:grid.4714.6 schema:alternateName Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
207 Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
208 schema:name Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
209 Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
210 Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden
211 IQVIA, Solna, Sweden
212 rdf:type schema:Organization
213 grid-institutes:grid.8993.b schema:alternateName Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden
214 schema:name Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden
215 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...